💊Daiichi Sankyo, Inc. Aligns U.S. Commercial Operations to Current Portfolio and Upcoming Cancer Pipeline Thursday March 1st, 2018By Tokio X'press Sales, Pharmaceutical daiichisankyo
MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia Therapies MD Anderson and Daiichi Sankyo Friday September 15th, 2017By Tokio X'press JPN, Pharmaceutical, USA daiichisankyo
Daiichi Sankyo Terminates Development and Commercialization Agreement with Charleston Laboratories Regarding Hydrocodone Products in the U.S., including CL-108 Daiichi Sankyo Terminates Deve Friday September 1st, 2017By Tokio X'press JPN, Pharmaceutical daiichisankyo